Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable dexlansoprazole vs lansoprazole for peptic ulcer bleeding
CTR20192098Phase 2Completed
- Sponsor
- Hunan Sailong Pharmaceutical Co., Ltd.
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexlansoprazole in upper gastrointestinal bleeding (UGIB), Peptic ulcer disease (PUD), sponsored by Hunan Sailong Pharmaceutical Co., Ltd.. Started Oct 2019; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on CTR20192098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192098.